Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 30;9:23247096211058489. doi: 10.1177/23247096211058489

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 American Federation for Medical Research

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — CT scans over the course of treatment with atezolizumab plus bevacizumab.

The upper panels show the right lung and the lower panels show the left ilium. (A) CT images before the initiation of treatment showing metastatic tumors (arrows). (B) CT image after the second course showing an increase in the size of the tumors (arrows). (C) CT image after the third course showing a decrease in size of the tumor (arrows). (D) CT images after the fourth course showing disappearance of the right lung tumor and a decrease in the left iliac tumor (arrows). (E) No recurrence of metastatic lung tumors, and further reduction in the left iliac tumor after the fifth course (arrows).

Abbreviation: CT, computed tomography.